Last 12 months
Inside the activity.
3 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 03, 2017 Filed Mar 7, 2017 22:45 UTC |
Brady Todd CDirector · President and CEO
|
GrantCommon Stock | 136,806 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-006712 · doc4.xml · nonDerivative · entry 1 Brady Todd C · CIK 0001579179 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,214 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on March 3, 2017, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 22:45 UTC |
Tulipano Stephen JChief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 220,980 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0000899243-17-006711 · doc4.xml · derivative · entry 1 Tulipano Stephen J · CIK 0001360548 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,980 Underlying: Common Stock · 220,980 shares Expires 2027-03-02 F1 · derivative.exercise_date: The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2017. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 21:33 UTC |
DOUGLAS RICHARDDirector
|
PurchaseCommon Stock | 40,000 | $4.50 | $180,000.00 |
DisclosureSEC source: 0000899243-17-004755 · doc4.xml · nonDerivative · entry 1 DOUGLAS RICHARD · CIK 0001021015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 F1 · price: Represents shares of common stock purchased by the Reporting Person in the Issuer's follow-on offering, which closed on February 17, 2017. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 16:30 UTC |
JOYCE MARTIN JOSEPHDirector
|
PurchaseCommon Stock | 4,444 | $4.50 | $19,998.00 |
DisclosureSEC source: 0000899243-17-004752 · doc4.xml · nonDerivative · entry 1 JOYCE MARTIN JOSEPH · CIK 0001300858 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,944 F1 · price: Represents shares of common stock purchased by the Reporting Person in the Issuer's follow-on offering, which closed on February 17, 2017. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 21:32 UTC |
Brady Todd CDirector · President and CEO
|
PurchaseCommon Stock | 22,223 | $4.50 | $100,003.50 |
DisclosureSEC source: 0000899243-17-004754 · doc4.xml · nonDerivative · entry 1 Brady Todd C · CIK 0001579179 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,408 F1 · price: Represents shares of common stock purchased by the Reporting Person in the Issuer's follow-on offering, which closed on February 17, 2017. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 21:31 UTC |
Bronstein BenDirector
|
PurchaseCommon Stock | 4,444 | $4.50 | $19,998.00 |
DisclosureSEC source: 0000899243-17-004753 · doc4.xml · nonDerivative · entry 1 Bronstein Ben · CIK 0001604458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,944 F1 · price: Represents shares of common stock purchased by the Reporting Person in the Issuer's follow-on offering, which closed on February 17, 2017. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 21:30 UTC |
Tulipano Stephen JChief Financial Officer
|
PurchaseCommon Stock | 3,333 | $4.50 | $14,998.50 |
DisclosureSEC source: 0000899243-17-004750 · doc4.xml · nonDerivative · entry 1 Tulipano Stephen J · CIK 0001360548 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,333 F1 · price: Represents shares of common stock purchased by the Reporting Person in the Issuer's follow-on offering, which closed on February 17, 2017. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 13:45 UTC |
PERCEPTIVE ADVISORS LLC10% owner
EDELMAN JOSEPH10% owner
|
PurchaseCommon Stock | 893,025 | $4.50 | $4,018,612.50 |
DisclosureSEC source: 0001019056-17-000215 · aldeyra_4.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 2,589,451 F1 · ownership.nature: This Form 4 is being filed by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"), Perceptive Advisors LLC (the "Advisor") and Joseph Edelman. The Advisor serves as the investment manager of the Master Fund. Mr. Edelman is the managing member of the Advisor. F2 · ownership.nature: This amount reflects the amount of securities held by the Master Fund immediately following the transaction requiring the filing of this statement. In accordance with Instruction 5(b)(iv) of Form 4, the entire amount of the Issuer's securities held by Master Fund is reported herein. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 13, 2016 Filed Sep 14, 2016 20:45 UTC |
DOUGLAS RICHARDDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 12,166 | $0.00 Strike: $5.62 | $0.00 |
DisclosureSEC source: 0000899243-16-028966 · doc4.xml · derivative · entry 1 DOUGLAS RICHARD · CIK 0001021015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,166 Underlying: Common Stock · 12,166 shares Expires 2026-09-12 F1 · derivative.exercise_date: Exercisable in equal annual installments over three years of continuous service to the Issuer after September 13, 2016. Read SEC document |
| May 01, 2014 Filed May 5, 2014 18:19 UTC |
JOHNSON & JOHNSON10% owner
|
Exercise / conversionSeries B Preferred Stock Warrant (Right to Buy) · Derivative | 36,345 | $0.00 Strike: $5.16 | $0.00 |
DisclosureSEC source: 0000904454-14-000410 · edgar.xml · derivative · entry 11 JOHNSON & JOHNSON · CIK 0000200406 · 10% owner JOHNSON & JOHNSON DEVELOPMENT CORP ET AL · CIK 0000924020 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Johnson & Johnson Development Corporation Disclosed balance after: 0 Underlying: Common Stock · 36,345 shares Expires 2018-08-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock immediately following declaration of effectiveness of the Issuer's Registration Statement for no additional consideration. Each share of Series A Preferred Stock and Non-Voting Series A Preferred Stock converted into shares of Common Stock on a 2.3726-for-1 basis and each share of Series B Preferred Stock and Non-Voting Series B Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis. F3 · derivative.exercise_date: All outstanding warrants were net exercised for shares of the Issuer's Series B Preferred Stock and subsequently automatically converted into Common Stock following declaration of effectiveness of the Issuer's Registration Statement for no additional consideration. Each share of Series B Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis. F2 · derivative.underlying: All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock immediately following declaration of effectiveness of the Issuer's Registration Statement for no additional consideration. Each share of Series A Preferred Stock and Non-Voting Series A Preferred Stock converted into shares of Common Stock on a 2.3726-for-1 basis and each share of Series B Preferred Stock and Non-Voting Series B Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis. F3 · derivative.underlying: All outstanding warrants were net exercised for shares of the Issuer's Series B Preferred Stock and subsequently automatically converted into Common Stock following declaration of effectiveness of the Issuer's Registration Statement for no additional consideration. Each share of Series B Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis. F1 · ownership.nature: The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person. Read SEC document |
| May 01, 2014 Filed May 5, 2014 18:19 UTC |
JOHNSON & JOHNSON10% owner
|
Exercise / conversionSeries B Preferred Stock Warrant (Right to Buy) · Derivative | 36,345 | $0.00 Strike: $5.16 | $0.00 |
DisclosureSEC source: 0000904454-14-000410 · edgar.xml · derivative · entry 10 JOHNSON & JOHNSON · CIK 0000200406 · 10% owner JOHNSON & JOHNSON DEVELOPMENT CORP ET AL · CIK 0000924020 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Johnson & Johnson Development Corporation Disclosed balance after: 0 Underlying: Common Stock · 36,345 shares Expires 2017-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock immediately following declaration of effectiveness of the Issuer's Registration Statement for no additional consideration. Each share of Series A Preferred Stock and Non-Voting Series A Preferred Stock converted into shares of Common Stock on a 2.3726-for-1 basis and each share of Series B Preferred Stock and Non-Voting Series B Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis. F3 · derivative.exercise_date: All outstanding warrants were net exercised for shares of the Issuer's Series B Preferred Stock and subsequently automatically converted into Common Stock following declaration of effectiveness of the Issuer's Registration Statement for no additional consideration. Each share of Series B Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis. F2 · derivative.underlying: All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock immediately following declaration of effectiveness of the Issuer's Registration Statement for no additional consideration. Each share of Series A Preferred Stock and Non-Voting Series A Preferred Stock converted into shares of Common Stock on a 2.3726-for-1 basis and each share of Series B Preferred Stock and Non-Voting Series B Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis. F3 · derivative.underlying: All outstanding warrants were net exercised for shares of the Issuer's Series B Preferred Stock and subsequently automatically converted into Common Stock following declaration of effectiveness of the Issuer's Registration Statement for no additional consideration. Each share of Series B Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis. F1 · ownership.nature: The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person. Read SEC document |
| May 01, 2014 Filed May 5, 2014 18:19 UTC |
JOHNSON & JOHNSON10% owner
|
ConversionNon-Voting Series B Preferred Stock · Derivative | 133,827 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-14-000410 · edgar.xml · derivative · entry 9 JOHNSON & JOHNSON · CIK 0000200406 · 10% owner JOHNSON & JOHNSON DEVELOPMENT CORP ET AL · CIK 0000924020 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Johnson & Johnson Development Corporation Disclosed balance after: 0 Underlying: Common Stock · 133,827 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock immediately following declaration of effectiveness of the Issuer's Registration Statement for no additional consideration. Each share of Series A Preferred Stock and Non-Voting Series A Preferred Stock converted into shares of Common Stock on a 2.3726-for-1 basis and each share of Series B Preferred Stock and Non-Voting Series B Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis. F2 · derivative.exercise_date: All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock immediately following declaration of effectiveness of the Issuer's Registration Statement for no additional consideration. Each share of Series A Preferred Stock and Non-Voting Series A Preferred Stock converted into shares of Common Stock on a 2.3726-for-1 basis and each share of Series B Preferred Stock and Non-Voting Series B Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis. F2 · derivative.expiration_date: All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock immediately following declaration of effectiveness of the Issuer's Registration Statement for no additional consideration. Each share of Series A Preferred Stock and Non-Voting Series A Preferred Stock converted into shares of Common Stock on a 2.3726-for-1 basis and each share of Series B Preferred Stock and Non-Voting Series B Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis. F1 · ownership.nature: The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person. Read SEC document |
| May 01, 2014 Filed May 5, 2014 18:19 UTC |
JOHNSON & JOHNSON10% owner
|
ConversionSeries B Preferred Stock · Derivative | 427,591 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-14-000410 · edgar.xml · derivative · entry 8 JOHNSON & JOHNSON · CIK 0000200406 · 10% owner JOHNSON & JOHNSON DEVELOPMENT CORP ET AL · CIK 0000924020 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Johnson & Johnson Development Corporation Disclosed balance after: 0 Underlying: Common Stock · 427,591 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock immediately following declaration of effectiveness of the Issuer's Registration Statement for no additional consideration. Each share of Series A Preferred Stock and Non-Voting Series A Preferred Stock converted into shares of Common Stock on a 2.3726-for-1 basis and each share of Series B Preferred Stock and Non-Voting Series B Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis. F2 · derivative.exercise_date: All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock immediately following declaration of effectiveness of the Issuer's Registration Statement for no additional consideration. Each share of Series A Preferred Stock and Non-Voting Series A Preferred Stock converted into shares of Common Stock on a 2.3726-for-1 basis and each share of Series B Preferred Stock and Non-Voting Series B Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis. F2 · derivative.expiration_date: All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock immediately following declaration of effectiveness of the Issuer's Registration Statement for no additional consideration. Each share of Series A Preferred Stock and Non-Voting Series A Preferred Stock converted into shares of Common Stock on a 2.3726-for-1 basis and each share of Series B Preferred Stock and Non-Voting Series B Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis. F1 · ownership.nature: The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person. Read SEC document |
| May 01, 2014 Filed May 5, 2014 18:19 UTC |
JOHNSON & JOHNSON10% owner
|
ConversionNon-Voting Series A Preferred Stock · Derivative | 104,396 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-14-000410 · edgar.xml · derivative · entry 7 JOHNSON & JOHNSON · CIK 0000200406 · 10% owner JOHNSON & JOHNSON DEVELOPMENT CORP ET AL · CIK 0000924020 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Johnson & Johnson Development Corporation Disclosed balance after: 0 Underlying: Common Stock · 247,694 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock immediately following declaration of effectiveness of the Issuer's Registration Statement for no additional consideration. Each share of Series A Preferred Stock and Non-Voting Series A Preferred Stock converted into shares of Common Stock on a 2.3726-for-1 basis and each share of Series B Preferred Stock and Non-Voting Series B Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis. F2 · derivative.exercise_date: All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock immediately following declaration of effectiveness of the Issuer's Registration Statement for no additional consideration. Each share of Series A Preferred Stock and Non-Voting Series A Preferred Stock converted into shares of Common Stock on a 2.3726-for-1 basis and each share of Series B Preferred Stock and Non-Voting Series B Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis. F2 · derivative.expiration_date: All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock immediately following declaration of effectiveness of the Issuer's Registration Statement for no additional consideration. Each share of Series A Preferred Stock and Non-Voting Series A Preferred Stock converted into shares of Common Stock on a 2.3726-for-1 basis and each share of Series B Preferred Stock and Non-Voting Series B Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis. F1 · ownership.nature: The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person. Read SEC document |
| May 01, 2014 Filed May 5, 2014 18:19 UTC |
JOHNSON & JOHNSON10% owner
|
ConversionSeries A Preferred Stock · Derivative | 385,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-14-000410 · edgar.xml · derivative · entry 6 JOHNSON & JOHNSON · CIK 0000200406 · 10% owner JOHNSON & JOHNSON DEVELOPMENT CORP ET AL · CIK 0000924020 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Johnson & Johnson Development Corporation Disclosed balance after: 0 Underlying: Common Stock · 915,366 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock immediately following declaration of effectiveness of the Issuer's Registration Statement for no additional consideration. Each share of Series A Preferred Stock and Non-Voting Series A Preferred Stock converted into shares of Common Stock on a 2.3726-for-1 basis and each share of Series B Preferred Stock and Non-Voting Series B Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis. F2 · derivative.exercise_date: All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock immediately following declaration of effectiveness of the Issuer's Registration Statement for no additional consideration. Each share of Series A Preferred Stock and Non-Voting Series A Preferred Stock converted into shares of Common Stock on a 2.3726-for-1 basis and each share of Series B Preferred Stock and Non-Voting Series B Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis. F2 · derivative.expiration_date: All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock immediately following declaration of effectiveness of the Issuer's Registration Statement for no additional consideration. Each share of Series A Preferred Stock and Non-Voting Series A Preferred Stock converted into shares of Common Stock on a 2.3726-for-1 basis and each share of Series B Preferred Stock and Non-Voting Series B Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis. F1 · ownership.nature: The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person. Read SEC document |
| May 01, 2014 Filed May 5, 2014 18:19 UTC |
JOHNSON & JOHNSON10% owner
|
Tax withholdingCommon Stock | 23,438 | $8.00 | $187,504.00 |
DisclosureSEC source: 0000904454-14-000410 · edgar.xml · nonDerivative · entry 5 JOHNSON & JOHNSON · CIK 0000200406 · 10% owner JOHNSON & JOHNSON DEVELOPMENT CORP ET AL · CIK 0000924020 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Johnson & Johnson Development Corporation Disclosed balance after: 1,750,292 F1 · ownership.nature: The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person. Read SEC document |
| May 01, 2014 Filed May 5, 2014 18:19 UTC |
JOHNSON & JOHNSON10% owner
|
Exercise / conversionCommon Stock | 36,345 | $5.16 | $187,540.20 |
DisclosureSEC source: 0000904454-14-000410 · edgar.xml · nonDerivative · entry 4 JOHNSON & JOHNSON · CIK 0000200406 · 10% owner JOHNSON & JOHNSON DEVELOPMENT CORP ET AL · CIK 0000924020 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Johnson & Johnson Development Corporation Disclosed balance after: 1,773,730 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person. Read SEC document |
| May 01, 2014 Filed May 5, 2014 18:19 UTC |
JOHNSON & JOHNSON10% owner
|
Tax withholdingCommon Stock | 23,438 | $8.00 | $187,504.00 |
DisclosureSEC source: 0000904454-14-000410 · edgar.xml · nonDerivative · entry 3 JOHNSON & JOHNSON · CIK 0000200406 · 10% owner JOHNSON & JOHNSON DEVELOPMENT CORP ET AL · CIK 0000924020 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Johnson & Johnson Development Corporation Disclosed balance after: 1,737,385 F1 · ownership.nature: The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person. Read SEC document |
| May 01, 2014 Filed May 5, 2014 18:19 UTC |
JOHNSON & JOHNSON10% owner
|
Exercise / conversionCommon Stock | 36,345 | $5.16 | $187,540.20 |
DisclosureSEC source: 0000904454-14-000410 · edgar.xml · nonDerivative · entry 2 JOHNSON & JOHNSON · CIK 0000200406 · 10% owner JOHNSON & JOHNSON DEVELOPMENT CORP ET AL · CIK 0000924020 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Johnson & Johnson Development Corporation Disclosed balance after: 1,760,823 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person. Read SEC document |
| May 01, 2014 Filed May 5, 2014 18:19 UTC |
JOHNSON & JOHNSON10% owner
|
ConversionCommon Stock | 1,724,478 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-14-000410 · edgar.xml · nonDerivative · entry 1 JOHNSON & JOHNSON · CIK 0000200406 · 10% owner JOHNSON & JOHNSON DEVELOPMENT CORP ET AL · CIK 0000924020 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Johnson & Johnson Development Corporation Disclosed balance after: 1,724,478 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock immediately following declaration of effectiveness of the Issuer's Registration Statement for no additional consideration. Each share of Series A Preferred Stock and Non-Voting Series A Preferred Stock converted into shares of Common Stock on a 2.3726-for-1 basis and each share of Series B Preferred Stock and Non-Voting Series B Preferred Stock automatically converted into shares of Common Stock on a 1-for-1 basis. F1 · ownership.nature: The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.